GlassScriptPhysician profile
Bridget S Rutledge
NPI 1083747067
$2,213.88
in general payments reported to CMS, 2019-2025
28 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $638 · 2020: $88.83 · 2021: $207 · 2022: $330 · 2023: $399 · 2024: $414 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $950.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $354.73 | 2023-2025 | Veozah |
| Abbvie INC. | $319.85 | 2019-2024 | Lo Loestrin Fe, Orilissa |
| Merck Sharp & Dohme LLC | $239.31 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $190.61 | 2019-2024 | |
| Myovant Sciences INC. | $181.95 | 2021-2022 | |
| Organon LLC | $127.24 | 2021-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $122.56 | 2023-2024 | Myfembree |
| Hologic Sales and Service, LLC | $83.88 | 2022-2025 | Fluent Fluid Management System, Third Wave, Thinprep 2000 Processor |
| Evofem Biosciences, INC. | $71.76 | 2021-2025 | Phexxi, Solosec, Phexx |
| Roche Diagnostics Corporation | $70.12 | 2019 | |
| Exeltis, USA INC. | $49.87 | 2022-2024 | Slynd |
| Agile Therapeutics, INC. | $44.89 | 2021-2024 | Twirla |
| Exact Sciences Corporation | $42.34 | 2023 | Cologuard Collection Kit |
| Lupin INC. | $35.71 | 2019 | |
| Avion Pharmaceuticals | $31.35 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $29.54 | 2024 | |
| Therapeuticsmd, INC. | $28.92 | 2019 | |
| Amag Pharmaceuticals, INC. | $28.91 | 2019 | |
| Karl Storz Endoscopy-America | $22.08 | 2020 | |
| Daiichi Sankyo INC. | $20.46 | 2021 | |
| Allergan, INC. | $17.43 | 2019 | |
| Medtronic, INC. | $16.85 | 2023 | V-Loc 180 |
| Abbott Laboratories | $15.39 | 2023 | Proclaim |
| Novo Nordisk INC | $15.32 | 2024 | Wegovy |
| Glaxosmithkline, LLC. | $15.18 | 2024 | Trelegy Ellipta, Arexvy |
| Mayne Pharma Commercial LLC | $15.12 | 2021 | |
| Coopersurgical, INC. | $11.66 | 2019 | |
| Meditrina | $10.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Rutledge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.